BSE – FREDUN
Auto Added by WPeMatico
BSE – FREDUN
Business
EBITDA
Financial Highlights
fredun pharmaceuticals
Mr. Fredun Medhora
Fredun Pharmaceuticals Reports 61 percent YoY Growth in EBITDA to INR 39.33 Cr in H1 FY26
Mumbai (Maharashtra) [India], November 11: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and animal healthcare products, has reported its Unaudited financials for Q2 FY26 & H1 FY26. Key Financial Highlights Q2 FY26 Standalone Financial Highlights • Total Income […]
Read More